News
A cell therapy preserves muscle structure and function in laboratory mice with a type of disease similar to Duchenne muscular ...
A 12-year-old boy from Carthage, Tennessee finds joy in his power wheelchair. His family are hoping for a cure for his muscular disease, Duchenne.
21h
GlobalData on MSNHansa’s Idefirix shows potential as pre-treatment to ElevidysHansa Biosciences’ Idefirix (imlifidase) has reduced patients’ antibodies to a level that allows dosing in patients with ...
The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.
Swedish biotech Hansa Biopharma on Friday released encouraging top-line results from three patients with Duchenne muscular ...
Deklan Locke, whose nickname is Flash, has a rare illness, Duchenne muscular dystrophy, which causes progressive muscle ...
SRPT's Q2 report, set to arrive Aug. 6, is likely to have Elevidys updates, restructuring plans and sales outlook in sharp investor focus.
Wave Life Sciences (WVE) stock gains as Canaccord Genuity launches its coverage with a Buy, citing multiple catalysts for the ...
Precision BioSciences Inc., a clinical-stage company developing gene editing therapies for diseases with high unmet need, has ...
The cost of high-end, breakthrough medications traumatizes patients and their families. According to USAfacts, “national ...
12h
Stockhead on MSNHealth Check: Audeara strives to be ‘the next Cochlear’ in affordable hearing collabHearing minnow Audeara has entered an alliance with Ear Science Institute Australia to develop an affordable bone conduction hearing device.
EIGHT YEAR OLD ATLAS COLEMAN IS IOWA’S KID CAPTAIN FOR THIS WEEK’S BIG GAME. DOESN’T GET ANY BIGGER THAN CY-HAWK, RIGHT? KCCI PEPPER EMPEROR TALKED WITH ATLAS AND HIS PARENTS TONIGHT ABOUT HIS JOURNEY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results